RadNet, Inc., a U.S. chief in outpatient diagnostic imaging companies, introduced it has acquired Gleamer SAS (“Gleamer”), a number one radiology AI firm primarily based in Paris, France, to be built-in into DeepHealth, RadNet’s wholly owned subsidiary. The acquisition additional expands DeepHealth’s AI-powered well being informatics options and companies, making it the biggest supplier of radiology scientific AI options worldwide.ii
With greater than 130 professionals, Gleamer is a quick rising, cloud-first, radiology AI firm serving greater than 700 buyer contracts in 44 nations in Europe and past. Its broad multimodality portfolio of FDA-cleared and CE-marked scientific AI and workflow options for musculoskeletal, breast, lung and neurologic functions is designed to enhance high quality of care whereas decreasing the radiologist workload. Gleamer’s prospects embrace hospitals, imaging facilities and healthcare methods, and its cloud platform drives a SaaS ARR enterprise mannequin.
Dr. Howard Berger, President and CEO of RadNet, commented: “As imaging volumes proceed to rise amid an accelerating scarcity of radiologists worldwide, reengineering high-volume workflows — notably routine imaging resembling X-ray, ultrasound and mammography — is turning into important to sustaining entry, effectivity and high quality of care. For radiologists and suppliers, the important thing lies in advancing automated examination prioritization and draft reporting. The acquisition of Gleamer uniquely positions DeepHealth to develop its influence throughout routine imaging and high-impact acute diagnostic care and speed up the supply of automated diagnostics.”
Additionally Learn: AiThority Interview With Arun Subramaniyan, Founder & CEO, Articul8 AI
The mixing of Gleamer’s portfolio with DeepHealth’s scientific AI suites of options for breast, chest, neuro, prostate and thyroid creates a complete portfolio unrivalled by some other radiology AI firm. The mixed portfolio helps screening, detection, interpretation and follow-up throughout most of the most prevalent most cancers varieties, in addition to neurodegenerative and musculoskeletal situations, together with trauma and persistent situations. With the inclusion of Gleamer’s merchandise, DeepHealth is now the worldwide chief in scientific AI options throughout MR, CT, X-ray, Mammography and Ultrasound modalities.
“Becoming a member of DeepHealth marks an thrilling new chapter for our enterprise and staff members,” stated Christian Allouche, Co-Founder and CEO of Gleamer. “Our staff has been pushed by a mission to enhance affected person care and entry, and we’re pleased with the influence we’ve had on our prospects and sufferers worldwide. By combining our AI capabilities, product portfolio and robust industrial staff with that of DeepHealth, we’re poised to form the way forward for clever imaging at scale.”
“We welcome Gleamer’s staff and capabilities into DeepHealth,” stated Kees Wesdorp, President and CEO of RadNet’s Digital Well being Division, DeepHealth. “This acquisition brings collectively two leaders on robust progress trajectories to create a brand new commonplace of AI-powered care. By constructing on our mixed strengths, we’re redefining how imaging is delivered, at scale, with intelligence and automation, to advance entry and effectivity whereas enhancing experiences and outcomes for sufferers and suppliers worldwide.”
Gleamer’s capabilities in automated reporting, already deployed in Europe, mixed with DeepHealth’s AI and informatics portfolio, convey scientific, generative and agentic AI and imaging informatics collectively into an built-in providing. With this intensive experience, DeepHealth is uniquely positioned to allow extra standardized interpretation, automated draft reporting and scalable diagnostic pathways.
Moreover, deploying Gleamer’s radiology AI and workflow capabilities throughout RadNet’s imaging community is predicted to create measurable productiveness beneficial properties, notably in X-ray, which accounts for nearly 25% of RadNet’s imaging quantity. RadNet intends to implement an end-to-end AI-enabled workflow that begins with triaging crucial findings to speed up the interpretation of probably the most pressing instances. The acquisition can even speed up the introduction of draft reporting capabilities, permitting radiologists to extend studying volumes with larger accuracy and standardization. This strategy will allow RadNet to optimize inside useful resource utilization, leading to improved operational and price efficiencies.
This acquisition is structured as an all-cash transaction, together with a post-closing milestone, and is valued at a purchase order worth of as much as €230 million. The valuation is reflective of Gleamer’s multi-year excessive recurring income progress, cloud-native gross margins, industry-leading buyer retention charges and its vast portfolio, inclusive of 4 FDA-cleared and 6 CE-marked gadgets supporting 25+ indications.
RadNet, Inc. is a number one nationwide supplier of freestanding, fixed-site diagnostic imaging companies in the USA primarily based on the variety of places and annual imaging income. RadNet has a community of owned and/or operated outpatient imaging facilities. RadNet’s markets embrace Arizona, California, Delaware, Florida, Indiana, Maryland, New Jersey, New York and Texas. As well as, RadNet gives radiology info know-how and synthetic intelligence options marketed beneath the DeepHealth model, teleradiology skilled companies and different associated services and products to prospects within the diagnostic imaging {industry}. Along with contracted radiologists, and inclusive of full-time and per diem staff and technologists, RadNet has over 11,000 staff members.
DeepHealth is an entirely owned subsidiary of RadNet, and serves because the umbrella model for RadNet’s Digital Well being phase. DeepHealth gives AI-powered well being informatics with the purpose of empowering breakthroughs in care by way of imaging.
DeepHealth leverages superior AI for operational effectivity and improved scientific outcomes in breast, chest, neuro, prostate and thyroid well being. On the coronary heart of DeepHealth’s portfolio is a cloud-first working system – DeepHealth OS – that unifies information throughout the scientific and operational workflow and personalizes AI-powered workspaces for everybody within the radiology continuum. 1000’s of imaging facilities and radiology departments around the globe use DeepHealth options to allow earlier, extra dependable and extra environment friendly illness detection, together with in large-scale most cancers screening packages. DeepHealth’s human-centered, intuitive know-how goals to push the boundaries of what’s potential in healthcare.
Based in 2017, Gleamer considers AI to be a key answer for addressing the sharp rise in demand for medical imaging, stemming from the challenges of an ageing inhabitants, the rising prevalence of persistent illnesses and the issues of entry to healthcare. The corporate’s suite of AI-powered options, throughout X-ray, mammography, CT and now, MRI, helps radiologists and clinicians of their diagnoses, thereby enhancing reliability and decreasing the time taken to learn and course of examinations. The relevance and distinctive efficiency of those options have been acknowledged worldwide because of 60 publications in extremely regarded peer-reviewed journals. With 30+ million exams analyzed throughout over 2,250 places, spanning 44 nations, Gleamer’s options are actually extensively acclaimed throughout the medical imaging {industry}.
Additionally Learn: Low cost and Quick: The Technique of LLM Cascading (Frugal GPT)
[To share your insights with us, please write to psen@itechseries.com ]
